# Role of a National Health Service Electronic Prescriptions Database in the Detection of Prescribing and Dispensing Issues and Adherence Evaluation of Direct Oral Anticoagulants

**Authors:** Anna Gavrilova, Maksims Zolovs, Dins Šmits, Anastasija Ņikitina, Gustavs Latkovskis, Inga Urtāne

PMC · DOI: 10.3390/healthcare12100975 · Healthcare · 2024-05-09

## TL;DR

This study uses a national prescription database to assess adherence to anticoagulant medications and finds that adherence levels are low.

## Contribution

The study leverages a national electronic prescription database to evaluate adherence and prescribing trends of DOACs over a decade.

## Key findings

- Only 44.2% of patients achieved an adherence level exceeding 80% to DOAC therapy.
- Dabigatran prescriptions declined after 2020, while warfarin prescriptions decreased since 2018.
- The use of paper prescriptions dropped significantly from 98.5% in 2017 to 1.3% in 2022.

## Abstract

Background: Anticoagulation therapy plays a crucial role in the management of atrial fibrillation (AF) by significantly reducing the risk of stroke. Direct oral anticoagulants (DOAC) became preferred over warfarin due to their superior safety and efficacy profile. Assessing adherence to anticoagulation therapy is necessary in clinical practice for optimising patient outcomes and treatment efficacy, thus emphasising its significance. Methods: A retrospective study utilised the Latvian National Health Service reimbursement prescriptions database, covering prescriptions for AF and flutter from January 2012 to December 2022. The proportion of days covered method was selected for adherence assessment, categorising it into three groups: (1) below 80%, (2) between 80% and 90%, and (3) above 90%. Results: A total of 1,646,648 prescriptions were analysed. Dabigatran prescriptions started declining after 2020, coinciding with a decrease in warfarin prescriptions since 2018. The total adherence levels to DOAC therapy were 69.4%. Only 44.2% of users achieved an adherence level exceeding 80%. The rate of paper prescriptions decreased from 98.5% in 2017 to 1.3% in 2022. Additionally, the utilisation of international non-proprietary names reached 79.7% in 2022. Specifically, 16.7% of patients selected a single pharmacy, whereas 27.7% visited one or two pharmacies. Meanwhile, other patients obtained medicines from multiple pharmacies. Conclusions: The total adherence level to DOAC therapy is evaluated as low and there was no significant difference in age, gender, or “switcher” status among adherence groups. Physicians’ prescribing habits have changed over a decade.

## Linked entities

- **Chemicals:** dabigatran (PubChem CID 216210), warfarin (PubChem CID 54678486)
- **Diseases:** atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** flutter (MESH:D054141), AF (MESH:D001281), stroke (MESH:D020521)
- **Chemicals:** warfarin (MESH:D014859), DOAC (-), Dabigatran (MESH:D000069604)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11121004/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11121004/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC11121004/full.md

---
Source: https://tomesphere.com/paper/PMC11121004